News

Roanoke College, Virginia Western Community College to support region as biotech corridor

Roanoke College and Virginia Western Community College are joining together to begin a new biotechnology bachelor’s degree program, according to officials.

The program is expected to begin this fall. Officials say the development of the four-year program is a direct response to the region’s need for a strategic workforce that can help elevate the Roanoke Valley and New River Valley as leaders in biomedical research.

Roanoke College and Virginia Western hope initiatives such as a $4.9 million grant for Project VITAL, a project aiming to create over 1,300 jobs within the next five years, along with investments in new lab facilities, startup incubators, and public-private partnerships, demonstrate that local and state leaders are committed to funding this growth.

“Together, we are rising to meet this pivotal moment and answer our region’s growing need for skilled professionals,” Roanoke College President Frank Shushok Jr. said. “Biotechnology is one of the most promising and transformative fields of the 21st century — advancing discovery, improving lives, and driving economic growth. By collaborating with Virginia Western and aligning with key state goals, we’re preparing students for the jobs of today and for the breakthroughs that will shape tomorrow.”

This four-year program is built upon an associate’s degree developed by Virginia Western in 2023. Administrators have decided to collaborate on this initiative as a partnership that benefits students at both colleges.

According to officials, students at Roanoke will take several courses at Virginia Western. Students at Virginia Western will have the opportunity for a transfer path to Roanoke College to continue their education.

“Our faculty are deeply committed to advancing the biotechnology sector in the Roanoke region,” said Virginia Western President Laura Treanor. “By combining hands-on laboratory training with Roanoke College’s bachelor-level coursework, our biotechnology students will graduate well-prepared, whether they choose to join the region’s growing biotech workforce or pursue advanced studies with confidence in their strong academic foundation.”

Roanoke College announced that it will begin accepting students for its biotechnology bachelor’s degree program this fall.

 

Read more here.

Recent News

10/20/2026

Supernus Reaches Key Milestone Toward Proposed Merger with Indivior Following Shareholder Approval

Supernus Pharmaceuticals, Inc. welcomed the decisive backing of shareholders today, who formally voted to approve the pending all-stock merger of equals. This vote marks an important milestone toward completing the merger announced in August 2026, with closing anticipated on November 2, 2026, subject to customary closing conditions. Following closing, the combined organization will officially commence …

10/20/2026

GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026

GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced 27 accepted scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting, highlighting how exome and genome sequencing are advancing scientific discovery, earlier diagnosis and more precise care. GeneDx research at ASHG 2026 highlights …

10/16/2026

Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis

Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”), which recently acquired Azora Therapeutics, today announced the appointment of David Rubenstein, M.D., Ph.D. as Chief Scientist. Dr. Rubenstein will lead the Company’s research and scientific strategy, including the continued development of AT177, a proprietary, oral, colon-targeted aryl hydrocarbon receptor (AhR) agonist being developed for the …